920 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Carcinoma, Bronchogenic" (920 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
3 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
4 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
5 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
6 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
7 Recruiting Study of Consolidation Chemotherapy For Bulky Local Advanced None-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: consolidation chemotherapy of AP or DP after CCRT
8 Not yet recruiting Anti-PD-L1 in Stage IIIA(N2) NSCLC
Condition: NSCLC Non-small Cell Lung Cancer
Intervention: Drug: MEDI4736 (anti-PD-L1)
9 Not yet recruiting A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies
Conditions: Gastric Cancer;   Gastroesophageal Junction Adenocarcinoma;   Non-Small Cell Lung Cancer;   Hepatocellular Carcinoma
Interventions: Drug: Ramucirumab;   Drug: MEDI4736
10 Not yet recruiting Robotic ICG Guided Surgery: A Novel Technique for Targeting Small Lung Tumors
Conditions: Non-small Cell Lung Cancer;   Thoracic Surgery
Intervention: Drug: Indocyanine Green
11 Not yet recruiting The Use of Systematically Injected Indocyanine Green in Robotic Segmentectomy
Condition: Non-small Cell Lung Cancer
Intervention: Drug: indocyanine green
12 Recruiting Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Docetaxel;   Drug: Paclitaxel;   Radiation: stereotactic radiosurgery
13 Not yet recruiting BIO 300 Non-Small Cell Lung Cancer Study
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BIO 300 Oral Suspension;   Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Radiotherapy
14 Not yet recruiting Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Conditions: Estrogen Receptor Negative;   Head and Neck Squamous Cell Carcinoma;   HER2/Neu Negative;   Hormone-Resistant Prostate Cancer;   Metastatic Pancreatic Adenocarcinoma;   Progesterone Receptor Negative;   Solid Neoplasm;   Stage III Mesothelioma;   Stage IIIA Gastric Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIA Small Cell Lung Carcinoma;   Stage IIIB Gastric Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIB Small Cell Lung Carcinoma;   Stage IIIC Gastric Cancer;   Stage IIIC Ovarian Cancer;   Stage IV Mesothelioma;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Ovarian Cancer;   Stage IV Small Cell Lung Carcinoma;   Triple-Negative Breast Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Talazoparib
15 Not yet recruiting Clinical Trial of Lurbinectedin (PM01183) Plus Doxorubicin (DOX) Versus Topotecan as Treatment in Patients With Small-Cell Lung Cancer (SCLC) Who Failed One Prior Platinum-containing Line
Condition: Small-cell Lung Cancer
Interventions: Drug: Lurbinectedin (PM01183);   Drug: Doxorubicin;   Drug: Topotecan
16 Not yet recruiting Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery
Conditions: Metastatic Neoplasm;   Recurrent Neoplasm;   Recurrent Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer;   Unresectable Malignant Neoplasm
Interventions: Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Targeted Therapy
17 Not yet recruiting Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC)
Condition: Metastatic Squamous Non-small Cell Lung Cancer
Interventions: Drug: Pembrolizumab;   Drug: Placebo
18 Not yet recruiting Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor
Conditions: Non-small Cell Lung Cancer;   Gastric Cancer;   Hepatocellular Carcinoma;   Colorectal Cancer
Intervention: Biological: natural killer T cell
19 Not yet recruiting SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer
Conditions: Carcinoma, Non-Small-Cell-Lung;   Non-Small Cell Lung Cancer;   Nonsmall Cell Lung Cancer
Interventions: Behavioral: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30;   Behavioral: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire LC-13;   Behavioral: Modified Medical Research Council;   Behavioral: EQ-5D;   Behavioral: Center for Epidemiological Studies Depression Scale;   Behavioral: Medical Outcomes Study Social Support Survey
20 Recruiting Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care
Condition: Non-Small Cell Lung Carcinoma (NSCLC)
Intervention: Other: Survey

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years